Immunologically privileged site

Revision as of 16:19, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Immunologically privileged site

Articles

Most recent articles on Immunologically privileged site

Most cited articles on Immunologically privileged site

Review articles on Immunologically privileged site

Articles on Immunologically privileged site in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Immunologically privileged site

Images of Immunologically privileged site

Photos of Immunologically privileged site

Podcasts & MP3s on Immunologically privileged site

Videos on Immunologically privileged site

Evidence Based Medicine

Cochrane Collaboration on Immunologically privileged site

Bandolier on Immunologically privileged site

TRIP on Immunologically privileged site

Clinical Trials

Ongoing Trials on Immunologically privileged site at Clinical Trials.gov

Trial results on Immunologically privileged site

Clinical Trials on Immunologically privileged site at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Immunologically privileged site

NICE Guidance on Immunologically privileged site

NHS PRODIGY Guidance

FDA on Immunologically privileged site

CDC on Immunologically privileged site

Books

Books on Immunologically privileged site

News

Immunologically privileged site in the news

Be alerted to news on Immunologically privileged site

News trends on Immunologically privileged site

Commentary

Blogs on Immunologically privileged site

Definitions

Definitions of Immunologically privileged site

Patient Resources / Community

Patient resources on Immunologically privileged site

Discussion groups on Immunologically privileged site

Patient Handouts on Immunologically privileged site

Directions to Hospitals Treating Immunologically privileged site

Risk calculators and risk factors for Immunologically privileged site

Healthcare Provider Resources

Symptoms of Immunologically privileged site

Causes & Risk Factors for Immunologically privileged site

Diagnostic studies for Immunologically privileged site

Treatment of Immunologically privileged site

Continuing Medical Education (CME)

CME Programs on Immunologically privileged site

International

Immunologically privileged site en Espanol

Immunologically privileged site en Francais

Business

Immunologically privileged site in the Marketplace

Patents on Immunologically privileged site

Experimental / Informatics

List of terms related to Immunologically privileged site


Overview

An immunologically privileged site is any of those locations in the body--the brain, anterior chamber of the eye, testis, renal tubule, uterus, and possibly joints and adrenal glands--where immune response to antigens are not destructive to tissue or is suppressed. It is necessary due to unique self-proteins that reside only in particular tissues and do not travel through the lymphatic system. Examples of tissue-specific proteins include myelin of the central nervous system. Such proteins are sequestered in organs and extracellular fluid does not travel the lymphatic system, meaning they do not come into contact with T cells during negative selection in the thymus. Allografts to these sites are not rejected.

Immune response is modified by the privileged sites through anti-inflammatory cytokine release of TGF-beta, which suppresses immune responses likely to cause tissue damage (favors B-cell antibody release vs. macrophage activation). Cells express FasL on their surface, which binds to cytotoxic T cells and causes the cytotoxic T cells to apoptose rather than destroy the tissue of privileged sites.

Medically, a cornea transplant is currently the only procedure that takes advantage of this.

references:[1] [2]


Template:WikiDoc Sources